Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Variations in Gene Expression and Response to Neoadjuvant Chemotherapy in Breast Carcinoma
Cancer Investigation, 05/29/09
Boidot R et al. - Comparison with histological response for both treatments revealed that only good responders exhibited changes in gene-expression profile. These results agree that expression of different genes changes in response to anthracycline-based neoadjuvant chemotherapy and show, for the first time, that response to docetaxel-based treatment implied also changes in gene-expression profile.
Related Articles
Invasive papillary carcinoma of the male breast: Report of a rare case and review of the literature
Journal of Cancer Research and Therapeutics, 10/28/09
Relevance Score: 70%
Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles
Histopathology, 11/12/09
Relevance Score: 68%
Analysis of the expression of hyaluronan in intraductal and invasive carcinomas of the breast
Journal of Cancer Research & Clinical Oncology, 11/10/09
Relevance Score: 68%
The Yale University Experience of Early-Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT)
The Breast Journal, 11/03/09
Relevance Score: 68%
High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer
Breast Cancer Research and Treatment, 10/28/09
Relevance Score: 68%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Predictive potential of angiogenic growth factors and circulating endothelial cells in breast cancer patients receiving metronomic chemotherapy plus bevacizumab
Clinical Cancer Research, 12/09/09
A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (≤ 1 cm) invasive breast cancer: Who might be possible candidates for adjuvant treatment?
Breast Cancer Research and Treatment, 12/09/09
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes
Breast Cancer Research, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


